Laurence Slutsker Selected Research

Laurence Slutsker Research Topics

Disease

77	Malaria 05/2024 - 01/2003
17	Infections 01/2022 - 05/2006
5	Bites and Stings (Sting) 01/2017 - 05/2006
3	Parasitemia 01/2021 - 12/2006
3	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2011 - 08/2008
2	Asymptomatic Infections 07/2019 - 01/2017
2	Tuberculosis (Tuberculoses) 10/2016 - 08/2012
2	Gastroenteritis 10/2016 - 05/2012
2	Opportunistic Infections (Opportunistic Infection) 10/2016 - 09/2008
2	Pneumonia (Pneumonitis) 10/2016 - 01/2009
2	Coinfection 01/2013 - 12/2008
2	HIV Infections (HIV Infection) 12/2008 - 12/2006
2	Anemia 07/2007 - 12/2006
1	Vesicular Stomatitis 12/2021
1	Vivax Malaria 04/2020
1	Febrile Seizures (Febrile Seizure) 10/2016
1	Human Influenza (Influenza) 10/2016
1	Malnutrition (Nutritional Deficiencies) 10/2016
1	Meningitis 10/2016
1	Sepsis (Septicemia) 10/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Spontaneous Abortion (Miscarriage) 11/2015
1	Reinfection 07/2013
1	Hookworm Infections (Hookworm Infection) 01/2009
1	Hypersensitivity (Allergy) 10/2006
1	Syphilis 04/2006
1	Iron Deficiencies 02/2006
1	Vitamin A Deficiency 02/2006
1	Aflatoxin Poisoning 12/2005
1	Diarrhea 06/2003

Drug/Important Bio-Agent (IBA)

12	Antimalarials (Antimalarial Agents)IBA 01/2017 - 06/2003
10	InsecticidesIBA 05/2024 - 02/2007
10	pyrimethamine drug combination fanasil (Fansidar)FDA Link 09/2014 - 06/2003
5	VaccinesIBA 12/2021 - 11/2011
5	Mefloquine (Lariam)FDA LinkGeneric 11/2018 - 04/2009
5	artemisinin (artemisinine)IBA 11/2015 - 04/2009
4	Pyrethrins (Pyrethroids)FDA Link 01/2021 - 10/2018
4	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2016 - 02/2007
4	Hemoglobins (Hemoglobin)IBA 03/2009 - 12/2006
4	Folic Acid (Vitamin M)FDA LinkGeneric 11/2008 - 04/2006
3	3-O-(methylthiomethyl)apiitol tetraacetateIBA 01/2021 - 01/2017
3	Folic Acid AntagonistsIBA 09/2014 - 09/2008
3	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 07/2013 - 06/2008
3	ArtesunateIBA 06/2010 - 04/2009
3	IronIBA 03/2007 - 02/2006
2	pirimiphos methyl (Aktel)IBA 06/2022 - 01/2021
2	SuspensionsIBA 09/2020 - 10/2018
2	artenimol (dihydroartemisinin)IBA 01/2020 - 07/2013
2	piperaquineIBA 01/2020 - 07/2013
2	Malaria VaccinesIBA 11/2015 - 12/2012
2	Biomarkers (Surrogate Marker)IBA 03/2015 - 12/2005
2	AntigensIBA 11/2014 - 12/2008
2	dapsone drug combination chloroguanilIBA 06/2010 - 04/2010
2	artesunate drug combination amodiaquineIBA 06/2010 - 04/2010
2	Drinking WaterIBA 01/2009 - 06/2003
1	SugarsIBA 05/2024
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	polyoxyethylene (2-methyl-2-propenyl) methyl diether-maleic anhydride copolymer (PM 100)IBA 01/2021
1	cypermethrin (alphamethrin)IBA 01/2021
1	N-methylchlorphentermineIBA 09/2020
1	OrganophosphatesIBA 08/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 04/2020
1	tafenoquineIBA 04/2020
1	Nevirapine (Viramune)FDA Link 11/2018
1	DDTIBA 10/2018
1	dimemorfan (AT 17)IBA 01/2017
1	Rabies Vaccines (Rabies Vaccine)FDA Link 10/2016
1	Sulfamethoxazole FDA LinkGeneric 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2013
1	Lumefantrine FDA Link 07/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Immunoglobulin Km AllotypesIBA 01/2013
1	Genetic Markers (Genetic Marker)IBA 01/2013
1	Probenecid (Benemid)FDA LinkGeneric 02/2012
1	KIR ReceptorsIBA 01/2012
1	Interleukin-12 (IL 12)IBA 03/2010
1	ElementsIBA 03/2010
1	hemozoinIBA 03/2009
1	Heme (Haem)IBA 03/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2009
1	EpitopesIBA 12/2008
1	AntibodiesIBA 12/2008
1	Interferon-gamma (Interferon, gamma)IBA 04/2008
1	Vitamin A (Retinol)FDA LinkGeneric 02/2006
1	Transferrin Receptors (Transferrin Receptor)IBA 02/2006

Therapy/Procedure

12	Insecticide-Treated Bednets 06/2022 - 06/2004
8	Chemoprevention 09/2020 - 06/2003
7	Mass Drug Administration 01/2020 - 12/2013
6	Therapeutics 04/2020 - 07/2006
3	Ambulatory Care (Outpatient Care) 05/2012 - 12/2007
2	Prenatal Care (Care, Prenatal) 12/2016 - 01/2003
1	Aftercare (After-Treatment) 07/2013